Mirae Asset Global ETFs Holdings’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Buy
58,962
+8,825
+18% +$196K ﹤0.01% 1409
2025
Q4
$1.07M Buy
50,137
+9,838
+24% +$173K ﹤0.01% 1472
2025
Q3
$470K Sell
40,299
-3,794
-9% -$37.7K ﹤0.01% 1894
2025
Q2
$408K Sell
44,093
-2,728
-6% -$22.4K ﹤0.01% 1914
2025
Q1
$316K Buy
46,821
+14,398
+44% +$138K ﹤0.01% 2086
2024
Q4
$343K Buy
32,423
+692
+2% +$8.36K ﹤0.01% 2101
2024
Q3
$463K Buy
31,731
+27,362
+626% +$389K ﹤0.01% 1954
2024
Q2
$52.3K Buy
+4,369
New +$68.3K ﹤0.01% 2781

Other funds holding IMNM

Mirae Asset Global ETFs Holdings's IMNM Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Immunome (IMNM) stake by 18% in Q1 2026, buying an estimated $196K and bringing the position to 58,962 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Mirae Asset Global ETFs Holdings first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 58,962 shares of Immunome worth $1.26M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 8,825 Immunome shares in Q1 2026, an estimated $196K.
  • Immunome made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1409 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.